https://doi.org/10.4081/reumatismo.2021.1397
Brachio-cervical inflammatory myopathy associated with systemic sclerosis. Case series and review of literature
Submitted: 13 January 2021
Accepted: 7 April 2021
Published: 3 August 2021
Accepted: 7 April 2021
Abstract Views: 3137
PDF: 778
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
This study was aimed at describing a case series of brachio-cervical inflammatory myopathy (BCIM) associated with systemic sclerosis (SSc), due to its rarity and limited coverage in published data. Another aim was to provide a literature review. We reported four cases of BCIM-SSc from our tertiary center. In addition, we researched the literature and found six articles featuring 17 patients who fit this phenotype. We pooled all cases and reported their features. Most patients were female and had limited SSc, and the median time of BCIM presentation was three years after SSc diagnosis. Asymmetric muscle involvement, scapular winging, dropped head, axial weakness, camptocormia, dysphagia, and dermatomyositis stigmas were common features. All patients had esophageal involvement. Most had positive antinuclear antibody results, a scleroderma pattern in their capillaroscopy images, elevated serum creatine phosphokinase, myopathic electrophysiology, and muscle involvement in magnetic resonance imaging. Muscle histopathological findings varied widely, but in general all showed the presence of lymphoid infiltrates, muscle atrophy, increased MHC-I expression, MAC deposits, vasculopathy, and muscle fiber necrosis. The response to immunosuppressive therapy was highly irregular. BCIM-SSc is a rare disorder that shares many similar phenotypes among the described cases, but has a highly heterogeneous response to treatment. At present, more data on the physiopathology, clinical features, and treatment is still needed.
Paik JJ. Myopathy in scleroderma and in other connective tissue diseases. Curr Opin Rheumatol. 2016; 28: 631-5.
DOI: https://doi.org/10.1097/BOR.0000000000000336
Paik JJ. Muscle disease in scleroderma. Curr Opin Rheumatol. 2018; 30: 576-80.
DOI: https://doi.org/10.1097/BOR.0000000000000552
Mimura Y, Ihn H, Jinnin M, et al. Clinical and laboratory features of scleroderma patients developing skeletal myopathy. Clin Rheumatol. 2005; 24: 99-102.
DOI: https://doi.org/10.1007/s10067-004-0975-7
Ranque B, Authier FJ, Berezne A, et al. Systemic sclerosis-associated myopathy. Ann N Y Acad Sci. 2007; 1108: 268-82.
DOI: https://doi.org/10.1196/annals.1422.029
Pestronk A, Kos K, Lopate G, Al-Lozi MT. Brachio-cervical inflammatory myopathies: Clinical, immune, and myopathologic features. Arthritis Rheum. 2006; 54: 1687-96.
DOI: https://doi.org/10.1002/art.21822
Garcin B, Lenglet T, Dubourg O, et al. Dropped head syndrome as a presenting sign of scleromyositis. J Neurol Sci. 2010; 292: 101-3.
DOI: https://doi.org/10.1016/j.jns.2010.02.015
Fernández-Serna M, Arboleya L, Alonso S, et al. Dropped head syndrome in a patient with scleromyositis. J Clin Rheumatol. 2013; 19: 32-4.
DOI: https://doi.org/10.1097/RHU.0b013e31827d8778
Yoshida T, Yoshida M, Mitsuyo K, et al. Dropped head syndrome and the presence of rimmed vacuoles in a muscle biopsy in scleroderma-polymyositis overlap syndrome associated with anti-ku antibody. Intern Med. 2018; 57: 887-91.
DOI: https://doi.org/10.2169/internalmedicine.9363-17
Rojana-Udomsart A, Fabian V, Hollingsworth PN, et al. Paraspinal and scapular myopathy associated with scleroderma. J Clin Neuromuscul Dis. 2010; 11: 213-22.
DOI: https://doi.org/10.1097/CND.0b013e3181c139f6
Gao AF, Saleh PA, Kassardjian CD, et al. Brachio-cervical inflammatory myopathy with associated scleroderma phenotype and lupus serology. Neurol Neuroimmunol Neuroinflammation. 2018; 5: 1-3.
DOI: https://doi.org/10.1212/NXI.0000000000000410
Suárez-Calvet X, Alonso-Pérez J, Castellví I, et al. Thrombospondin-1 mediates muscle damage in brachio-cervical inflammatory myopathy and systemic sclerosis. Neurol Neuroimmunol Neuroinflammation. 2020; 7: e694.
DOI: https://doi.org/10.1212/NXI.0000000000000694
van den Hoogen F, Khanna D, Fransen J, et al. 2013 Classification criteria for systemic sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative. Arthritis Rheum. 2013; 65: 2737-47.
DOI: https://doi.org/10.1002/art.38098
Lundberg IE, Tjärnlund A, Bottai M, et al. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheumatol. 2017; 69: 2271-82.
DOI: https://doi.org/10.1002/art.40320
Audet GN, Fulks D, Stricker JC, Olfert IM. Chronic delivery of a thrombospondin-1 mimetic decreases skeletal muscle capillarity in mice. PLoS One. 2013; 8: e55953.
DOI: https://doi.org/10.1371/journal.pone.0055953
Salajegheh M, Raju R, Schmidt J, Dalakas MC. Upregulation of thrombospondin-1(TSP-1) and its binding partners, CD36 and CD47, in sporadic inclusion body myositis. J Neuroimmunol. 2007; 187: 166-74.
DOI: https://doi.org/10.1016/j.jneuroim.2007.04.022
Phelan MW, Forman LW, Perrine SR, Faller DV. Hypoxia increases thrombospondin-1 transcript and protein in cultured endothelial cells. J Lab Clin Med. 1998; 132: 519-29.
DOI: https://doi.org/10.1016/S0022-2143(98)90131-7
Mansfield PJ, Suchard SJ. Thrombospondin promotes chemotaxis and haptotaxis of human peripheral blood monocytes. J Immunol. 1994; 153: 4219-29.
Le Quintrec JS, Le Quintrec JL. Drug-induced myopathies. Baillieres Clin Rheumatol. 1991; 5: 21-38.
DOI: https://doi.org/10.1016/S0950-3579(05)80294-8
Aydintug AO, Cervera R, D’Cruz D, et al. Polymyositis complicating D-penicillamine treatment. Postgrad Med. J 1991; 67: 1018-20.
DOI: https://doi.org/10.1136/pgmj.67.793.1018
Preedy VR, Marway JS, Baldwin D, et al. Experimental D-penicillamine-induced myopathy. Biochem Soc Trans. 1996; 24: 2403.
DOI: https://doi.org/10.1042/bst024266s
Sato N, Okamoto S, Mori T, et al Recurrent acute myositis after allogeneic bone marrow transplantation for myelodysplasia. Hematology. 2002; 7: 109-12.
DOI: https://doi.org/10.1080/10245330290022115
Oda K, Nakaseko C, Ozawa S, et al. Fasciitis and myositis: An analysis of muscle-related complications caused by chronic GVHD after allo-SCT. Bone Marrow Transplant. 2009; 43: 159-67.
DOI: https://doi.org/10.1038/bmt.2008.297
Hedermann G, Marquart H, Vissing J. Polymyositis following autologous haematopoietic stem cell transplantation. Scand J Rheumatol 2016; 45: 429-31.
DOI: https://doi.org/10.3109/03009742.2015.1125525
Radke J, Pehl D, Aronica E, et al. The lymphoid follicle variant of dermatomyositis. Neurol Neuroimmunol Neuroinflammation. 2014; 1: e19.
DOI: https://doi.org/10.1212/NXI.0000000000000019
De Padilla CML, Vallejo AN, Lacomis D, et al. Extranodal lymphoid microstructures in inflamed muscle and disease severity of new-onset Juvenile dermatomyositis. Arthritis Rheum. 2009; 60: 1160-72.
DOI: https://doi.org/10.1002/art.24411
Radke J, Koll R, Preuße C, et al Architectural B-cell organization in skeletal muscle identifies subtypes of dermatomyositis. Neurol Neuroimmunol Neuroinflammation. 2018; 5: e451.
DOI: https://doi.org/10.1212/NXI.0000000000000451
Jung M, Bonner A, Hudson M, et al.; Canadian Scheroderma Research Group (CSRG). Myopathy is a poor prognostic feature in systemic sclerosis: results from the Canadian Scleroderma Research Group (CSRG) cohort. Scand J Rheumatol. 2014; 43: 217-20.
DOI: https://doi.org/10.3109/03009742.2013.868512
Chaigne B, Rodeia S, Benmostefa N, et al Corticosteroid-sparing benefit of intravenous immunoglobulin in systemic sclerosis-associated myopathy: A comparative study in 52 patients. Autoimmun Rev. 2020; 19: 102431.
DOI: https://doi.org/10.1016/j.autrev.2019.102431
Ranque B, Authier FJ, Le-Guern V, et al. A descriptive and prognostic study of systemic sclerosis-associated myopathies. Ann Rheum Dis. 2009; 68: 1474-7.
DOI: https://doi.org/10.1136/ard.2008.095919
How to Cite
Araujo, C., Miossi, R., De Souza, F., Costa, M., da Silva, A., Campos, E., … Shinjo, S. (2021). Brachio-cervical inflammatory myopathy associated with systemic sclerosis. Case series and review of literature. Reumatismo, 73(2), 122–130. https://doi.org/10.4081/reumatismo.2021.1397
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Similar Articles
- T. Borges, A. Barbosa, S. Silva, Adult-onset systemic autoinflammatory disorders: a clinical approach , Reumatismo: Vol. 71 No. 4 (2019)
- C.K. Tan, E. Suresh, Cervical and lumbar paraspinal calcinosis in systemic sclerosis , Reumatismo: Vol. 68 No. 4 (2016)
- F.J. Aceves-Avila, M. Chávez-López, J.R. Chavira-González, C. Ramos-Remus, Temporomandibular joint dysfunction in various rheumatic diseases , Reumatismo: Vol. 65 No. 3 (2013)
- L. De Falco, A. Fioravanti, M. Galeazzi, S. Tenti, Bradykinin and its role in osteoarthritis , Reumatismo: Vol. 65 No. 3 (2013)
- L. Punzi, M. Chia, S. Cipolletta, C. Dolcetti, P. Galozzi, O. Giovinazzi, S. Tonolo, R. Zava, F. Pazzaglia, The role of architectural design for rheumatic patients’ wellbeing: the point of view of Environmental Psychology , Reumatismo: Vol. 72 No. 1 (2020)
- R. Torta, F. Pennazio, V. Ieraci, Anxiety and depression in rheumatologic diseases: the relevance of diagnosis and management , Reumatismo: Vol. 66 No. 1 (2014)
- S. Chandrashekara, V. Shobha, B.G. Dharmanand, R. Jois, S. Kumar, K.M. Mahendranath, V. Haridas, S. Prasad, Y. Singh, M.A. Daware, A. Swamy, R. Subramanian, S.A. Somashekar, A.M. Shanthappa, K.R. Anupama, Comorbidities and related factors in rheumatoid arthritis patients of south India- Karnataka Rheumatoid Arthritis Comorbidity (KRAC) study , Reumatismo: Vol. 69 No. 2 (2017)
- D. Fornasari, S. Coaccioli, Pharmacology of pain , Reumatismo: Vol. 66 No. 1 (2014)
- M. Varenna, F. Bertoldo, M. Di Monaco, A. Giusti, G. Martini, M. Rossini, On behalf of SIOMMMS, Endorsed by SIR, Safety profile of drugs used in the treatment of osteoporosis: a systematical review of the literature , Reumatismo: Vol. 65 No. 4 (2013)
- C. Ferrone, R. Andracco, M.A. Cimmino, Calcium pyrophosphate deposition disease: clinical manifestations , Reumatismo: Vol. 63 No. 4 (2011): Special issue • Microcrystalline Arthritis
<< < 6 7 8 9 10 11 12 13 14 15 > >>
You may also start an advanced similarity search for this article.
